Upstate Active Clinical Trials

Study Title:

NRG-GY022 - Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin

What is the purpose of the study? (in Layman's terms, please describe the study)

This study is being done to answer the following question:

How can we better calculate the dose of carboplatin for an individual patient?

Upstate Institutional Review Board (IRB) Number:

2104911

Study/Protocol ID:

NRG-GY022

Study Phase:

1

Patient Age Group:

Adults

Principal Investigator:

Alina Basnet

What is involved if I participate?

• How long is the study?
  4 weeks
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  Administration of iohexol and blood draws

Where will the study take place?

Upstate Cancer Center Downtown

Other Information:

n/a

ClinicalTrials.Gov ID:

NCT03997370

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Laine Abernathy
Phone: 315-464-6528
Email: [email protected]

Return to Previous Page || Search Again